Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron for Distal Ureteral Stones (ChiCTR2000035203)
ChiCTR2000035203Phase 4Recruiting
- Sponsor
- Nanjing Medical University Affiliated Nanjing Hospital
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of mirabegron in ureterolithiasis (4 arms), sponsored by Nanjing Medical University Affiliated Nanjing Hospital. Primary endpoints: Stone expulsion ratio, Stone expulsion interval and 1 more. Started Aug 2020; status: recruiting.
02
Drugs
mirabegron
03
Conditions
ureterolithiasis
Beyond the preview
Go deeper on ChiCTR2000035203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035203.